查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595317

醫藥中間體市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Pharmaceutical Intermediates Market by Type (GMP, Non GMP), Application (Analgesics, Antibiotics, Antipyretic), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫藥中間體市場價值為314.4億美元，預計2024年將達到339.9億美元，複合年成長率為8.19%，到2030年將達到545.5億美元。

醫藥中間體市場廣闊，涵蓋合成活性藥物成分 (API) 所必需的化合物。這些中間體充當可管理且高效的藥物製造過程的化學前體。對藥物中間體的需求源於對創新藥物和治療方法不斷成長的需求，推動了新的給藥途徑和製劑的持續開發。這些中間體主要用於藥品製造，在腫瘤、心血管疾病和感染疾病等治療領域有廣泛的應用。最終用途廣泛，包括製藥商、契約製造組織和研究機構。市場成長是由製藥業擴張、技術進步以及研發投資增加等因素所推動的。對具有成本效益、高品質的藥品製造的需求正在推動契約製造和專業承包商擴大其服務。此外，生技藥品和生物相似藥的興起以及新興市場對醫療保健基礎設施的投資提供了一條成長之路。儘管形勢樂觀，但挑戰包括嚴格的監管要求使核准流程複雜化以及全球分銷管道的差異影響及時進入市場。此外，在遵守高品質標準的同時保持成本效益仍然是一個限制。一個合適的創新領域是開發永續生產中間體的綠色化學工藝，同時解決經濟和環境問題。此外，中間研究中高通量篩檢技術的擴展有可能加快藥物發現時間。透過技術進步毒害新興市場並促進資源最佳化的策略夥伴關係可能會提高市場滲透率。市場的本質是動態和競爭的，其特點是強力的監管監督和不斷發展的全球標準，而技術創新和不斷擴大的醫療保健需求提供了巨大的商機。這些見解要求相關人員專注於永續實踐和適應性強的業務策略，以有效利用成長潛力。

主要市場統計
基準年[2023] 314.4億美元
預測年份 [2024] 339.9億美元
預測年份 [2030] 545.5億美元
複合年成長率（%） 8.19%

市場動態：揭示快速發展的醫藥中間體市場的關鍵市場洞察

醫藥中間體市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和生活方式相關疾病增加
    • 各藥廠資金籌措快速增加
    • 臨床研究中較採用醫藥中間體
  • 市場限制因素
    • 與活性藥物成分相關的副作用
  • 市場機會
    • 製藥業正在進行的研究和開發活動
    • 策略聯盟投資與產能擴張
  • 市場挑戰
    • 有關藥品行銷的嚴格規則和規定

波特五力：駕馭醫藥中間體市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對醫藥中間體市場的影響

外部宏觀環境因素對醫藥中間體市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫藥中間體市場競爭狀況

對醫藥中間體市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣醫藥中間體市場供應商績效評估

FPNV定位矩陣是評估醫藥中間體市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪醫藥中間體市場的成功之路

醫藥中間體市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和文明病增加
      • 各藥廠資金籌措快速增加
      • 臨床研究中較採用醫藥中間體
    • 抑制因素
      • 與活性藥物成分相關的副作用
    • 機會
      • 製藥業的持續研發活動
      • 策略聯盟和投資以擴大產能
    • 任務
      • 嚴格的藥品上市規則和規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章醫藥中間體市場：依類型

  • 品管標準
  • 非GMP

第7章醫藥中間體市場：依應用分類

  • 止痛藥
  • 抗生素
  • 退燒劑
  • 維他命

第8章醫藥中間體市場：依最終用戶分類

  • 契約製造組織
  • 製藥公司
  • 研究室

第9章美洲醫藥中間體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫藥中間體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲醫藥中間體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aceto Corporation
  • AGC Group
  • BASF SE
  • Codexis, Inc.
  • Cycle Pharma
  • Dishman Group
  • Easter Chemical Corporation
  • Life Sciences Private Limited
  • Nectar Lifesciences Limited
  • Noah Chemicals
  • Proviron Holding NV
  • Sanofi SA
  • SAREX
  • Vertellus Holdings LLC
  • ZCL Chemicals Ltd.
Product Code: MRR-030EE48515E9

The Pharmaceutical Intermediates Market was valued at USD 31.44 billion in 2023, expected to reach USD 33.99 billion in 2024, and is projected to grow at a CAGR of 8.19%, to USD 54.55 billion by 2030.

The market for pharmaceutical intermediates is broad, encompassing compounds crucial in synthesizing active pharmaceutical ingredients (APIs). These intermediates serve as the chemical precursors to manageable and efficient drug manufacturing processes. The need for pharmaceutical intermediates arises from the increasing demand for innovative drugs and therapies, driving the continuous development of new medication routes and formulations. Primarily utilized in drug manufacturing, these intermediates find extensive application in therapeutic areas like oncology, cardiovascular diseases, and infectious diseases. Their end-use spans pharmaceutical manufacturers, contract manufacturing organizations, and research institutes. Market growth is bolstered by factors such as the expanding pharmaceutical industry, technological advancements, and increasing R&D investments. The demand for cost-efficient and quality pharmaceutical manufacturing catalyzes opportunities for contract manufacturers and specialized suppliers to expand services. Additionally, the rise of biologics and biosimilars presents a growth avenue, alongside the emerging markets investing in healthcare infrastructure. Despite the promising landscape, challenges include stringent regulatory requirements, which complicate the approval process and discrepancies in global distribution channels affecting timely market access. Furthermore, maintaining cost-effectiveness while adhering to high-quality standards remains a limitation. A pertinent area for innovation is the development of green chemistry processes to produce intermediates sustainably, which would address both economic and environmental considerations. Also, expanding high-throughput screening techniques in intermediate research could accelerate drug discovery timelines. Poisoning emerging markets with technological advancements and fostering strategic partnerships for resource optimization would enhance market penetration. The nature of the market is dynamic and competitive, with substantial opportunities driven by technological innovations and expanding healthcare needs, yet characterized by rigorous regulatory scrutiny and evolving global standards. These insights mandate stakeholders to focus on sustainable practices and adaptable business strategies to harness potential growth effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 31.44 billion
Estimated Year [2024] USD 33.99 billion
Forecast Year [2030] USD 54.55 billion
CAGR (%) 8.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of chronic and lifestyle-driven diseases
    • Surge in the funding by various drug-making companies
    • Rising adoption of pharmaceutical intermediates in clinical research
  • Market Restraints
    • Side effects related to the active pharmaceutical ingredients
  • Market Opportunities
    • Ongoing research and development activities in the pharmaceutical industry
    • Strategic alliances and investment for capacity expansion
  • Market Challenges
    • Strict rules and regulations to launch pharmaceutical drugs

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Intermediates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Intermediates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Intermediates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Intermediates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Intermediates Market

A detailed market share analysis in the Pharmaceutical Intermediates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Intermediates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Intermediates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Intermediates Market

A strategic analysis of the Pharmaceutical Intermediates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aceto Corporation, AGC Group, BASF SE, Codexis, Inc., Cycle Pharma, Dishman Group, Easter Chemical Corporation, Life Sciences Private Limited, Nectar Lifesciences Limited, Noah Chemicals, Proviron Holding NV, Sanofi S.A., SAREX, Vertellus Holdings LLC, and ZCL Chemicals Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across GMP and Non GMP.
  • Based on Application, market is studied across Analgesics, Antibiotics, Antipyretic, and Vitamins.
  • Based on End-User, market is studied across Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of chronic and lifestyle-driven diseases
      • 5.1.1.2. Surge in the funding by various drug-making companies
      • 5.1.1.3. Rising adoption of pharmaceutical intermediates in clinical research
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects related to the active pharmaceutical ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities in the pharmaceutical industry
      • 5.1.3.2. Strategic alliances and investment for capacity expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Strict rules and regulations to launch pharmaceutical drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. GMP
  • 6.3. Non GMP

7. Pharmaceutical Intermediates Market, by Application

  • 7.1. Introduction
  • 7.2. Analgesics
  • 7.3. Antibiotics
  • 7.4. Antipyretic
  • 7.5. Vitamins

8. Pharmaceutical Intermediates Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Manufacturing Organizations
  • 8.3. Pharmaceutical Companies
  • 8.4. Research Labs

9. Americas Pharmaceutical Intermediates Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Intermediates Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Intermediates Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aceto Corporation
  • 2. AGC Group
  • 3. BASF SE
  • 4. Codexis, Inc.
  • 5. Cycle Pharma
  • 6. Dishman Group
  • 7. Easter Chemical Corporation
  • 8. Life Sciences Private Limited
  • 9. Nectar Lifesciences Limited
  • 10. Noah Chemicals
  • 11. Proviron Holding NV
  • 12. Sanofi S.A.
  • 13. SAREX
  • 14. Vertellus Holdings LLC
  • 15. ZCL Chemicals Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL INTERMEDIATES MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY GMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY NON GMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIPYRETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023